Pruritus and restless legs syndrome (RLS) frequently affect patients with chronic kidney disease (CKD) and end-stage kidney disease (ESKD), impacting quality of life. Gabapentin alleviates these symptoms in hemodialysis (HD) patients but data are lacking for patients on the conservative pathway.